$Cassava Sciences (SAVA.US)$ 处于单边下跌状态，还没看到止跌迹象

$Cassava Sciences (SAVA.US)$ This Open Letter is definitely showing that SAVA is about treating patients with AD and debunks all the crap the shorts have done for 3+ years.  ’I am happy to inform you that our ReTHINK Phase 3 clinical trial recently completed its last patient, last visit. All patients have completed dosing, and all that remains is to collect and analyze the data. For a company our size, this is a remarkable achievement. This study enrolled 804 patients at 77 sites in the US, Puert...

$3倍做多半导体ETF-Direxion (SOXL.US)$ 我没有拥有它的时候，它长得很好，当我一旦买了它之后，它就不涨不跌或者止跌不涨。

$3倍做多半导体ETF-Direxion (SOXL.US)$ 什么情况？

$3倍做多半导体ETF-Direxion (SOXL.US)$
我相信今天双杀 杀完做多 再杀做空 短期交易者注定被市场波动击败 对于长期投资的交易者来说这些波动都是属于正常现象

$3倍做多半导体ETF-Direxion (SOXL.US)$ 今天收盘价32.67，信不信由你。😂

$3倍做多半导体ETF-Direxion (SOXL.US)$ 锁定您的利润

$3倍做多半导体ETF-Direxion (SOXL.US)$ 半导体完了，持续阴跌

$Cassava Sciences (SAVA.US)$ Thanks Vinnie “Dr Jack Lu, a well known economist, based on event studies assessed a P3 drug is worth $20B.
$SAVA presently is valued @ $1.43B. A huge disconnect w/ a SAFE DRUG read out in EOY.
Do you think FDA knows something which we don’t irrespective 🩳s pushing the trials to stop?”

$3倍做多半导体ETF-Direxion (SOXL.US)$ 今晚会升至34度吗？